Cukras Catherine, Huynh Nancy, Vitale Susan, Wong Wai T, Ferris Fredrick L, Sieving Paul A
Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Ophthalmology. 2015 Feb;122(2):356-66. doi: 10.1016/j.ophtha.2014.07.056. Epub 2014 Oct 14.
To compare subjective and objective clinical tests used in the screening for hydroxychloroquine retinal toxicity to multifocal electroretinography (mfERG) reference testing.
Prospective, single-center, case control study.
Fifty-seven patients with a previous or current history of hydroxychloroquine treatment of more than 5 years' duration.
Participants were evaluated with a detailed medical history, dilated ophthalmologic examination, color fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain (SD) optical coherence tomography (OCT), automated visual field testing (10-2 visual field mean deviation [VFMD]), and mfERG testing. We used mfERG test parameters as a gold standard to divide participants into 2 groups: those affected by hydroxychloroquine-induced retinal toxicity and those unaffected.
We assessed the association of various imaging and psychophysical variables in the affected versus the unaffected group.
Fifty-seven study participants (91.2% female; mean age, 55.7±10.4 years; mean duration of hydroxychloroquine treatment, 15.0±7.5 years) were divided into affected (n = 19) and unaffected (n = 38) groups based on mfERG criteria. Mean age and duration of hydroxychloroquine treatment did not differ statistically between groups. Mean OCT retinal thickness measurements in all 9 macular subfields were significantly lower (<40 μm) in the affected group (P < 0.01 for all comparisons) compared with those in the unaffected group. Mean VFMD was 11 dB lower in the affected group (P < 0.0001). Clinical features indicative of retinal toxicity were scored for the 2 groups and were detected in 68.4% versus 0.0% using color fundus photographs, 73.3% versus 9.1% using FAF images, and 84.2% versus 0.0% on the scoring for the perifoveal loss of the photoreceptor ellipsoid zone on SD-OCT for affected and unaffected participants, respectively. Using a polynomial modeling approach, OCT inner ring retinal thickness measurements and Humphrey 10-2 VFMD were identified as the variables associated most strongly with the presence of hydroxychloroquine as defined by mfERG testing.
Optical coherence tomography retinal thickness and 10-2 VFMD are objective measures demonstrating clinically useful sensitivity and specificity for the detection of hydroxychloroquine toxicity as identified by mfERG, and thus may be suitable surrogate tests.
比较用于筛查羟氯喹视网膜毒性的主观和客观临床检查与多焦视网膜电图(mfERG)参考检测。
前瞻性、单中心、病例对照研究。
57例有既往或当前羟氯喹治疗史且疗程超过5年的患者。
对参与者进行详细病史评估、散瞳眼科检查、彩色眼底照相、眼底自发荧光(FAF)成像、光谱域(SD)光学相干断层扫描(OCT)、自动视野检测(10-2视野平均偏差[VFMD])以及mfERG检测。我们将mfERG检测参数作为金标准,将参与者分为两组:受羟氯喹诱导的视网膜毒性影响的患者和未受影响的患者。
我们评估了受影响组与未受影响组中各种成像和心理物理学变量之间的关联。
57例研究参与者(91.2%为女性;平均年龄55.7±10.4岁;羟氯喹治疗平均疗程15.0±7.5年)根据mfERG标准分为受影响组(n = 19)和未受影响组(n = 38)。两组之间的平均年龄和羟氯喹治疗疗程在统计学上无差异。与未受影响组相比,受影响组所有9个黄斑亚区的平均OCT视网膜厚度测量值均显著更低(<40μm)(所有比较P < 0.01)。受影响组的平均VFMD低11dB(P < 0.0001)。对两组进行了指示视网膜毒性的临床特征评分,使用彩色眼底照片时,受影响组和未受影响组的检出率分别为68.4%和0.0%;使用FAF图像时分别为73.3%和9.1%;在SD-OCT上对受影响和未受影响参与者的中央凹周围光感受器椭圆体带缺失进行评分时,分别为84.2%和0.0%。使用多项式建模方法,OCT内环视网膜厚度测量值和汉弗莱10-2 VFMD被确定为与mfERG检测所定义的羟氯喹存在最密切相关的变量。
光学相干断层扫描视网膜厚度和10-2 VFMD是客观指标,对检测mfERG所确定的羟氯喹毒性具有临床上有用的敏感性和特异性,因此可能是合适的替代检测方法。